Brookline, MA, United States of America

Abhishek Kulkarni

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 9.8

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Abhishek Kulkarni: Innovator in Biocircuit Systems and Immunotherapy

Introduction

Abhishek Kulkarni is a prominent inventor based in Brookline, MA (US). He has made significant contributions to the field of biocircuit systems and immunotherapy, holding a total of 3 patents. His work focuses on developing innovative solutions that enhance therapeutic modalities.

Latest Patents

Kulkarni's latest patents include "Membrane bound IL12 compositions and methods for tunable regulation." This patent provides regulatable biocircuit systems that offer modular and tunable protein expression systems. These systems support the discovery and development of therapeutic modalities. Another notable patent is "PDE5 compositions and methods for immunotherapy," which relates to compositions and methods for the regulated and controlled expression of proteins. This invention also includes methods for inducing anti-cancer immune responses in a subject.

Career Highlights

Abhishek Kulkarni is currently associated with Obsidian Therapeutics, Inc., where he continues to push the boundaries of innovation in his field. His work is instrumental in advancing therapeutic approaches that can significantly impact patient care.

Collaborations

Kulkarni collaborates with talented individuals such as Vipin Suri and Dexue Sun, contributing to a dynamic and innovative work environment.

Conclusion

Abhishek Kulkarni's contributions to biocircuit systems and immunotherapy exemplify his commitment to innovation and improving therapeutic modalities. His patents reflect a deep understanding of the complexities of protein expression and its applications in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…